Influence of glycosylation inhibition on the binding of KIR3DL1 to HLA-B∗57:01

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Salzberger, Wilhelm ^a   Garcia Beltran, Wilfredo F ^b   Dugan, Haley ^b   Gubbala, Supreetha ^b   Simoneau, Camille ^b   Gressens, Simon B ^b   Jost, Stephanie ^b   Altfeld, Marcus ^a,b  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; TUNICAMYCIN; ENZYME INHIBITOR; HLA-B*57:01 ANTIGEN; KIR3DL1 PROTEIN, HUMAN; PROTEIN BINDING;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DEGRANULATION; HUMAN; HUMAN CELL; JURKAT CELL LINE; NATURAL KILLER CELL; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION; CELL CULTURE; DRUG EFFECTS; GLYCOSYLATION; METABOLISM;

CELLS, CULTURED; ENZYME INHIBITORS; GLYCOSYLATION; HLA-B ANTIGENS; HUMANS; JURKAT CELLS; KILLER CELLS, NATURAL; PROTEIN BINDING; RECEPTORS, KIR3DL1; TUNICAMYCIN;

EID: 84957581317     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145324     Document Type: Article

References (41)

1. Campbell KS, Hasegawa J. Natural killer cell biology: an update and future directions. The Journal of allergy and clinical immunology. 2013;132(3):536-44. Epub 2013/08/03. doi: 10.1016/j.jaci.2013.07. 006 PMID: 23906377; PubMed Central PMCID: PMCPmc3775709.
2. Orange JS. Human natural killer cell deficiencies. Current opinion in allergy and clinical immunology. 2006;6(6):399-409. doi: 10.1097/ACI.0b013e3280106b65 PMID: 17088643.
3. Wu J, Lanier LL. Natural killer cells and cancer. Advances in cancer research. 2003;90:127-56. PMID: 14710949.
4. Altfeld M, Gale M Jr. Innate immunity against HIV-1 infection. Nat Immunol. 2015;16(6):554-62. doi: 10.1038/ni.3157 PMID: 25988887.
5. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annual review of immunology. 2013;31:227-58. Epub 2013/03/23. doi: 10.1146/annurev-immunol-020711-075005 PMID: 23516982; PubMed Central PMCID: PMCPmc3868343.
6. Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, Carrington M, et al. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. Journal of virology. 2011;85(12):5970-4. doi: 10.1128/JVI.00412-11 PMID: 21471246; PubMed Central PMCID: PMC3126328.
7. ∗ 0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function. PLoS pathogens. 2012;8(7):e1002805. doi: 10.1371/journal. ppat.1002805 PMID: 22807681; PubMed Central PMCID: PMC3395618.
8. Körner C, Altfeld M. Role of KIR3DS1 in human diseases. Frontiers in immunology. 2012;3:326. doi: 10.3389/fimmu.2012.00326 PMID: 23125843.
9. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annual review of genomics and human genetics. 2006;7:277-300. doi: 10.1146/annurev. genom.7.080505.115726 PMID: 16824023.
10. Alter G, Rihn S, Walter K, Nolting a, Martin M, Rosenberg ES, et al. HLA Class I Subtype-Dependent Expansion of KIR3DS1+ and KIR3DL1+ NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection. Journal of virology. 2009;83:6798-805. doi: 10.1128/JVI.00256-09 PMID: 19386717.
11. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature. 2011;476(7358):96-100. doi: 10.1038/nature10237 PMID: 21814282; PubMed Central PMCID: PMC3194000.
12. Bieberich E. Synthesis, Processing, and Function of N-glycans in N-glycoproteins. Advances in neuroBiology. 2014;9:47-70. doi: 10.1007/978-1-4939-1154-7-3 PMID: 25151374; PubMed Central PMCID: PMC4236024.
13. Moremen KW, Tiemeyer M, Nairn AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nature reviews Molecular cell Biology. 2012;13(7):448-62. doi: 10.1038/nrm3383 PMID: 22722607; PubMed Central PMCID: PMC3934011.
14. Barbosa JA, Santos-Aguado J, Mentzer SJ, Strominger JL, Burakoff SJ, Biro PA. Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition. The Journal of experimental medicine. 1987;166(5):1329-50. PMID: 2445888; PubMed Central PMCID: PMC2189648.
15. Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG. The IPD and IMGT/HLA database: allele variant databases. Nucleic Acids Res. 2015;43(Database issue):D423-31. doi: 10.1093/nar/gku1161 PMID: 25414341; PubMed Central PMCID: PMC4383959.
16. Schonthal AH. Endoplasmic reticulum stress: its role in disease and novel prospects for therapy. Scientifica. 2012;2012:857516. doi: 10.6064/2012/857516 PMID: 24278747; PubMed Central PMCID: PMC3820435.
17. Esko JD, Bertozzi CR. Chemical Tools for Inhibiting Glycosylation. 2009. Epub 2010/03/20. doi: NBK1938 [bookaccession]. PMID: 20301258.
18. van Kemenade FJ, Rotteveel FT, van den Broek LA, Baars PA, van Lier RA, Miedema F. Glucosidase trimming inhibitors preferentially perturb T cell activation induced by CD2 mAb. Journal of leukocyte Biology. 1994;56(2):159-65. PMID: 7915296.
19. ∗57. Journal of virology. 2011;85(12):5949-60. doi: 10.1128/JVI.02652-10 PMID: 21471235; PubMed Central PMCID: PMC3126301.
20. ∗03:04 and modulate primary natural killer cell function. Aids. 2014;28(10):1399-408. doi: 10.1097/QAD. 0000000000000284 PMID: 24785948; PubMed Central PMCID: PMC4453925.
21. Glassy MC, Ferrone S. Ultrastructural alterations in human lymphoblastoid B cell lines treated with tunicamycin. The American journal of pathology. 1981;103(1):1-9. PMID: 6971575; PubMed Central PMCID: PMC1903799.
22. Cella M, Colonna M. Cloning human natural killer cells. Methods in molecular Biology. 2000;121:1-4. doi: 10.1385/1-59259-044-6:1 PMID: 10818711.
23. Bagriacik EU, Kirkpatrick A, Miller KS. Glycosylation of native MHC class Ia molecules is required for recognition by allogeneic cytotoxic T lymphocytes. GlycoBiology. 1996;6(4):413-21. PMID: 8842705.
24. Ploegh HL, Orr HT, Stominger JL. Biosynthesis and cell surface localization of nonglycosylated human histocompatibility antigens. Journal of immunology (Baltimore, Md: 1950). 1981;126(1):270-5. PMID: 7005335.
25. Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, Beddoe T, et al. Killer cell immunoglobulinlike receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature. 2011;479(7373):401-5. doi: 10.1038/nature10517 PMID: 22020283; PubMed Central PMCID: PMC3723390.
26. Storkus WJ, Alexander J, Payne JA, Cresswell P, Dawson JR. The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing. Journal of immunology (Baltimore, Md: 1950). 1989;143(11):3853-7. PMID: 2479694.
27. Goldstein SA, Mescher MF. Carbohydrate moieties of major histocompatibility complex class I alloantigens are not required for their recognition by T lymphocytes. The Journal of experimental medicine. 1985;162(4):1381-6. PMID: 3876403; PubMed Central PMCID: PMC2187872.
28. Hart GW. The role of asparagine-linked oligosaccharides in cellular recognition by thymic lymphocytes. Effects of tunicamycin on the mixed lymphocyte reaction. The Journal of biological chemistry. 1982;257(1):151-8. PMID: 6458612.
29. Miyazaki J, Appella E, Zhao H, Forman J, Ozato K. Expression and function of a nonglycosylated major histocompatibility class I antigen. The Journal of experimental medicine. 1986;163(4):856-71. PMID: 2419473; PubMed Central PMCID: PMC2188082.
30. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998;391(6669):795-9. doi: 10.1038/35869 PMID: 9486650.
31. Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest. 2013;123(5):2183-92. doi: 10.1172/JCI65708 PMID: 23563315; PubMed Central PMCID: PMC3637034.
32. Chung AW, Crispin M, Pritchard L, Robinson H, Gorny MK, Yu X, et al. Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function. Aids. 2014;28(17):2523-30. doi: 10.1097/QAD.0000000000000444 PMID: 25160934; PubMed Central PMCID: PMC4429604.
33. Vestrheim AC, Moen A, Egge-Jacobsen W, Reubsaet L, Halvorsen TG, Bratlie DB, et al. A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines. Immunity, inflammation and disease. 2014;2(2):76-91. doi: 10.1002/iid3.22 PMID: 25400928; PubMed Central PMCID: PMC4217548.
34. Parham P, Alpert BN, Orr HT, Strominger JL. Carbohydrate moiety of HLA antigens. Antigenic properties and amino acid sequences around the site of glycosylation. The Journal of biological chemistry. 1977;252(21):7555-67. PMID: 72068.
35. Barber LD, Patel TP, Percival L, Gumperz JE, Lanier LL, Phillips JH, et al. Unusual uniformity of the Nlinked oligosaccharides of HLA-A, -B, and -C glycoproteins. Journal of immunology (Baltimore, Md: 1950). 1996;156(9):3275-84. PMID: 8617950.
36. Nagae M, Yamaguchi Y. Function and 3D structure of the N-glycans on glycoproteins. International journal of molecular Sciences. 2012;13(7):8398-429. doi: 10.3390/ijms13078398 PMID: 22942711; PubMed Central PMCID: PMC3430242.
37. Paabo S, Nilsson T, Peterson PA. Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. Proc Natl Acad Sci U S A. 1986;83(24):9665-9. PMID: 3467330; PubMed Central PMCID: PMC387201.
38. Tardif KD, Siddiqui A. Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells. Journal of virology. 2003;77(21):11644-50. PMID: 14557650; PubMed Central PMCID: PMC229359.
39. Raska M, Takahashi K, Czernekova L, Zachova K, Hall S, Moldoveanu Z, et al. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. The Journal of biological chemistry. 2010;285(27):20860-9. doi: 10.1074/jbc. M109.085472 PMID: 20439465; PubMed Central PMCID: PMC2898351.
40. Lanteri M, Giordanengo V, Hiraoka N, Fuzibet JG, Auberger P, Fukuda M, et al. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. GlycoBiology. 2003;13(12):909-18. doi: 10.1093/glycob/cwg110 PMID: 12925577.
41. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997;18(15):2714-23. doi: 10.1002/elps.1150181505 PMID: 9504803.